APO Research
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Diagnostics

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Selected research

Industry Growth & Trends

Global In-Vitro Diagnostics Industry Growth and Trends Forecast to 2032

25 December 2025110 pages

Choose your research edition.

Industry ResearchIn-Vitro Diagnostics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Diagnostics Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal In-Vitro Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Diagnostics Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Diagnostics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

According to APO Research, the global In-Vitro Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global In-Vitro Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The In-Vitro Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In-Vitro Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In-Vitro Diagnostics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global In-Vitro Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

In-Vitro Diagnostics Market by Company

Roche

Siemens

Abbott

Danaher

Thermo Fisher

BioMerieux

Bio-Rad

BD

JNJ

Sysmex

KHB

DaAn Gene

Leadman

BioSino

BSBE

Maccura

In-Vitro Diagnostics Segment by Type

Tissue Diagnostics

Professional Diagnostic

Molecular Diagnostic

Diabetes Monitoring

Other

In-Vitro Diagnostics Segment by Application

Diabetes

Infectious Diseases

Oncology

Cardiology

HIV

Other

In-Vitro Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of In-Vitro Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Diagnostics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global In-Vitro Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global In-Vitro Diagnostics Market Share by Region (2021-2026) Table 4. Global In-Vitro Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global In-Vitro Diagnostics Market Share by Region (2027-2032) Table 6. Global In-Vitro Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global In-Vitro Diagnostics Market Size Share by Type (2021-2026) Table 9. Global In-Vitro Diagnostics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global In-Vitro Diagnostics Market Size Share Forecasted by Type (2027-2032) Table 11. North America In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America In-Vitro Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe In-Vitro Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America In-Vitro Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global In-Vitro Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global In-Vitro Diagnostics Market Size Share by Application (2021-2026) Table 24. Global In-Vitro Diagnostics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global In-Vitro Diagnostics Market Size Share Forecasted by Application (2027-2032) Table 26. North America In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America In-Vitro Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe In-Vitro Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America In-Vitro Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. In-Vitro Diagnostics Industry Trends Table 37. In-Vitro Diagnostics Industry Drivers Table 38. In-Vitro Diagnostics Industry Opportunities and Challenges Table 39. In-Vitro Diagnostics Industry Restraints Table 40. Global In-Vitro Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global In-Vitro Diagnostics Revenue Market Share by Company (2021-2026) Table 42. Global In-Vitro Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global In-Vitro Diagnostics Key Company Headquarters & Area Served Table 44. Global In-Vitro Diagnostics Company, Product Type & Application Table 45. Global In-Vitro Diagnostics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche In-Vitro Diagnostics Product Portfolio Table 52. Roche Recent Development Table 53. Siemens Company Information Table 54. Siemens Business Overview Table 55. Siemens In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Siemens In-Vitro Diagnostics Product Portfolio Table 57. Siemens Recent Development Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Abbott In-Vitro Diagnostics Product Portfolio Table 62. Abbott Recent Development Table 63. Danaher Company Information Table 64. Danaher Business Overview Table 65. Danaher In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Danaher In-Vitro Diagnostics Product Portfolio Table 67. Danaher Recent Development Table 68. Thermo Fisher Company Information Table 69. Thermo Fisher Business Overview Table 70. Thermo Fisher In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Thermo Fisher In-Vitro Diagnostics Product Portfolio Table 72. Thermo Fisher Recent Development Table 73. BioMerieux Company Information Table 74. BioMerieux Business Overview Table 75. BioMerieux In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. BioMerieux In-Vitro Diagnostics Product Portfolio Table 77. BioMerieux Recent Development Table 78. Bio-Rad Company Information Table 79. Bio-Rad Business Overview Table 80. Bio-Rad In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bio-Rad In-Vitro Diagnostics Product Portfolio Table 82. Bio-Rad Recent Development Table 83. BD Company Information Table 84. BD Business Overview Table 85. BD In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. BD In-Vitro Diagnostics Product Portfolio Table 87. BD Recent Development Table 88. JNJ Company Information Table 89. JNJ Business Overview Table 90. JNJ In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. JNJ In-Vitro Diagnostics Product Portfolio Table 92. JNJ Recent Development Table 93. Sysmex Company Information Table 94. Sysmex Business Overview Table 95. Sysmex In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sysmex In-Vitro Diagnostics Product Portfolio Table 97. Sysmex Recent Development Table 98. KHB Company Information Table 99. KHB Business Overview Table 100. KHB In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. KHB In-Vitro Diagnostics Product Portfolio Table 102. KHB Recent Development Table 103. DaAn Gene Company Information Table 104. DaAn Gene Business Overview Table 105. DaAn Gene In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. DaAn Gene In-Vitro Diagnostics Product Portfolio Table 107. DaAn Gene Recent Development Table 108. Leadman Company Information Table 109. Leadman Business Overview Table 110. Leadman In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Leadman In-Vitro Diagnostics Product Portfolio Table 112. Leadman Recent Development Table 113. BioSino Company Information Table 114. BioSino Business Overview Table 115. BioSino In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BioSino In-Vitro Diagnostics Product Portfolio Table 117. BioSino Recent Development Table 118. BSBE Company Information Table 119. BSBE Business Overview Table 120. BSBE In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. BSBE In-Vitro Diagnostics Product Portfolio Table 122. BSBE Recent Development Table 123. Maccura Company Information Table 124. Maccura Business Overview Table 125. Maccura In-Vitro Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Maccura In-Vitro Diagnostics Product Portfolio Table 127. Maccura Recent Development Table 128. North America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America In-Vitro Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 130. North America In-Vitro Diagnostics Market Share by Country (2021-2026) Table 131. North America In-Vitro Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America In-Vitro Diagnostics Market Share Forecast by Country (2027-2032) Table 133. Europe In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe In-Vitro Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe In-Vitro Diagnostics Market Share by Country (2021-2026) Table 136. Europe In-Vitro Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe In-Vitro Diagnostics Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific In-Vitro Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific In-Vitro Diagnostics Market Share by Country (2021-2026) Table 141. Asia-Pacific In-Vitro Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific In-Vitro Diagnostics Market Share Forecast by Country (2027-2032) Table 143. Latin America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America In-Vitro Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America In-Vitro Diagnostics Market Share by Country (2021-2026) Table 146. Latin America In-Vitro Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America In-Vitro Diagnostics Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2021-2026) Table 151. Middle East & Africa In-Vitro Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa In-Vitro Diagnostics Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. In-Vitro Diagnostics Product Image Figure 3. Global In-Vitro Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 5. Global In-Vitro Diagnostics Market Share by Region: 2025 VS 2032 Figure 6. Global In-Vitro Diagnostics Market Share by Region (2021-2032) Figure 7. North America In-Vitro Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe In-Vitro Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America In-Vitro Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tissue Diagnostics Image Figure 13. Global Tissue Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Professional Diagnostic Image Figure 15. Global Professional Diagnostic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Molecular Diagnostic Image Figure 17. Global Molecular Diagnostic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Diabetes Monitoring Image Figure 19. Global Diabetes Monitoring Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global In-Vitro Diagnostics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global In-Vitro Diagnostics Market Share by Type 2025 VS 2032 Figure 24. North America In-Vitro Diagnostics Market Size Share by Type (2021-2032) Figure 25. Europe In-Vitro Diagnostics Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific In-Vitro Diagnostics Market Size Share by Type (2021-2032) Figure 27. Latin America In-Vitro Diagnostics Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa In-Vitro Diagnostics Market Size Share by Type (2021-2032) Figure 29. Diabetes Image Figure 30. Global Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Infectious Diseases Image Figure 32. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Oncology Image Figure 34. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Cardiology Image Figure 36. Global Cardiology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. HIV Image Figure 38. Global HIV Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Other Image Figure 40. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global In-Vitro Diagnostics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global In-Vitro Diagnostics Market Share by Application 2025 VS 2032 Figure 43. North America In-Vitro Diagnostics Market Size Share by Application (2021-2032) Figure 44. Europe In-Vitro Diagnostics Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific In-Vitro Diagnostics Market Size Share by Application (2021-2032) Figure 46. Latin America In-Vitro Diagnostics Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa In-Vitro Diagnostics Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America In-Vitro Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America In-Vitro Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 53. Europe In-Vitro Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe In-Vitro Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 56. Asia-Pacific In-Vitro Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific In-Vitro Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 59. Latin America In-Vitro Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America In-Vitro Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 62. Middle East & Africa In-Vitro Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa In-Vitro Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Diagnostics
  • Professional Diagnostic
  • Molecular Diagnostic
  • Diabetes Monitoring
  • Other
Applications
  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • HIV
  • Other
Companies covered
  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • JNJ
  • Sysmex
  • KHB
  • DaAn Gene
  • Leadman
  • BioSino
  • BSBE
  • Maccura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global In-Vitro Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global In-Vitro Diagnostics Market Size by Region (2021-2032)
  5. 1.4.1 Global In-Vitro Diagnostics Market Size by Region (2021-2026)
  6. 1.4.2 Global In-Vitro Diagnostics Market Size by Region (2027-2032)
  7. 1.5 Key Regions In-Vitro Diagnostics Market Size (2021-2032)
  8. 1.5.1 North America In-Vitro Diagnostics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe In-Vitro Diagnostics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America In-Vitro Diagnostics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (2021-2032)
2 In-Vitro Diagnostics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tissue Diagnostics
  3. 2.1.2 Professional Diagnostic
  4. 2.1.3 Molecular Diagnostic
  5. 2.1.4 Diabetes Monitoring
  6. 2.1.5 Other
  7. 2.2 Global In-Vitro Diagnostics Market Size by Type
  8. 2.2.1 Global In-Vitro Diagnostics Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global In-Vitro Diagnostics Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global In-Vitro Diagnostics Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global In-Vitro Diagnostics Market Size by Regions
  12. 2.3.1 North America In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Type (2021-2026)
3 In-Vitro Diagnostics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Diabetes
  3. 3.1.2 Infectious Diseases
  4. 3.1.3 Oncology
  5. 3.1.4 Cardiology
  6. 3.1.5 HIV
  7. 3.1.6 Other
  8. 3.2 Global In-Vitro Diagnostics Market Size by Application
  9. 3.2.1 Global In-Vitro Diagnostics Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global In-Vitro Diagnostics Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global In-Vitro Diagnostics Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global In-Vitro Diagnostics Market Size by Regions
  13. 3.3.1 North America In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 In-Vitro Diagnostics Industry Trends
  2. 4.2 In-Vitro Diagnostics Industry Drivers
  3. 4.3 In-Vitro Diagnostics Industry Opportunities and Challenges
  4. 4.4 In-Vitro Diagnostics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by In-Vitro Diagnostics Revenue (2021-2026)
  2. 5.2 Global In-Vitro Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global In-Vitro Diagnostics Key Company Headquarters & Area Served
  4. 5.4 Global In-Vitro Diagnostics Company, Product Type & Application
  5. 5.5 Global In-Vitro Diagnostics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 In-Vitro Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche In-Vitro Diagnostics Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Siemens
  8. 6.2.1 Siemens Company Information
  9. 6.2.2 Siemens Business Overview
  10. 6.2.3 Siemens In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Siemens In-Vitro Diagnostics Product Portfolio
  12. 6.2.5 Siemens Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Abbott In-Vitro Diagnostics Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Danaher
  20. 6.4.1 Danaher Company Information
  21. 6.4.2 Danaher Business Overview
  22. 6.4.3 Danaher In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Danaher In-Vitro Diagnostics Product Portfolio
  24. 6.4.5 Danaher Recent Developments
  25. 6.5 Thermo Fisher
  26. 6.5.1 Thermo Fisher Company Information
  27. 6.5.2 Thermo Fisher Business Overview
  28. 6.5.3 Thermo Fisher In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
  30. 6.5.5 Thermo Fisher Recent Developments
  31. 6.6 BioMerieux
  32. 6.6.1 BioMerieux Company Information
  33. 6.6.2 BioMerieux Business Overview
  34. 6.6.3 BioMerieux In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
  36. 6.6.5 BioMerieux Recent Developments
  37. 6.7 Bio-Rad
  38. 6.7.1 Bio-Rad Company Information
  39. 6.7.2 Bio-Rad Business Overview
  40. 6.7.3 Bio-Rad In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
  42. 6.7.5 Bio-Rad Recent Developments
  43. 6.8 BD
  44. 6.8.1 BD Company Information
  45. 6.8.2 BD Business Overview
  46. 6.8.3 BD In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 BD In-Vitro Diagnostics Product Portfolio
  48. 6.8.5 BD Recent Developments
  49. 6.9 JNJ
  50. 6.9.1 JNJ Company Information
  51. 6.9.2 JNJ Business Overview
  52. 6.9.3 JNJ In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 JNJ In-Vitro Diagnostics Product Portfolio
  54. 6.9.5 JNJ Recent Developments
  55. 6.10 Sysmex
  56. 6.10.1 Sysmex Company Information
  57. 6.10.2 Sysmex Business Overview
  58. 6.10.3 Sysmex In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
  60. 6.10.5 Sysmex Recent Developments
  61. 6.11 KHB
  62. 6.11.1 KHB Company Information
  63. 6.11.2 KHB Business Overview
  64. 6.11.3 KHB In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 KHB In-Vitro Diagnostics Product Portfolio
  66. 6.11.5 KHB Recent Developments
  67. 6.12 DaAn Gene
  68. 6.12.1 DaAn Gene Company Information
  69. 6.12.2 DaAn Gene Business Overview
  70. 6.12.3 DaAn Gene In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
  72. 6.12.5 DaAn Gene Recent Developments
  73. 6.13 Leadman
  74. 6.13.1 Leadman Company Information
  75. 6.13.2 Leadman Business Overview
  76. 6.13.3 Leadman In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Leadman In-Vitro Diagnostics Product Portfolio
  78. 6.13.5 Leadman Recent Developments
  79. 6.14 BioSino
  80. 6.14.1 BioSino Company Information
  81. 6.14.2 BioSino Business Overview
  82. 6.14.3 BioSino In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BioSino In-Vitro Diagnostics Product Portfolio
  84. 6.14.5 BioSino Recent Developments
  85. 6.15 BSBE
  86. 6.15.1 BSBE Company Information
  87. 6.15.2 BSBE Business Overview
  88. 6.15.3 BSBE In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 BSBE In-Vitro Diagnostics Product Portfolio
  90. 6.15.5 BSBE Recent Developments
  91. 6.16 Maccura
  92. 6.16.1 Maccura Company Information
  93. 6.16.2 Maccura Business Overview
  94. 6.16.3 Maccura In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Maccura In-Vitro Diagnostics Product Portfolio
  96. 6.16.5 Maccura Recent Developments
7 North America
  1. 7.1 North America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America In-Vitro Diagnostics Market Size by Country (2021-2026)
  3. 7.3 North America In-Vitro Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe In-Vitro Diagnostics Market Size by Country (2021-2026)
  3. 8.3 Europe In-Vitro Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific In-Vitro Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America In-Vitro Diagnostics Market Size by Country (2021-2026)
  3. 10.3 South America In-Vitro Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa In-Vitro Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst